← Back to headlines
Wolfe Research Bullish on Eli Lilly's Obesity Pipeline
Wolfe Research maintains a bullish outlook on Eli Lilly and Company, citing strong prospects for its pipeline of obesity drugs and potential market growth.
28 May, 11:37 — 28 May, 11:37
Sources
Showing 1 of 1 sources
